Description
Product Description
Paclitaxel Polymeric Micelle represents an innovative nanoformulation approach to enhance the pharmacokinetic and biopharmaceutical properties of paclitaxel, one of the most widely studied microtubule-stabilizing anticancer compounds. Due to its poor aqueous solubility and systemic toxicity when administered as a conventional formulation, researchers have turned to polymeric micelles to improve its solubility, circulation stability, and targeted delivery efficiency.
This advanced nanocarrier system encapsulates paclitaxel within amphiphilic copolymers—typically PEG-PLA, PEG-PCL, or other biodegradable polymers—to form nanoscale micellar structures. These micelles possess a hydrophobic core that solubilizes paclitaxel and a hydrophilic shell that stabilizes dispersion in aqueous environments. The resulting system provides extended circulation time, passive tumor targeting via the enhanced permeability and retention (EPR) effect, and reduced systemic toxicity.
In oncology research, Paclitaxel Polymeric Micelle is extensively used to study nanoparticle-based pharmacokinetics, cellular uptake, intracellular trafficking, and tumor accumulation. It offers a reliable model for exploring controlled drug release mechanisms, polymer-drug compatibility, and biodistribution in both in vitro and in vivo studies.
Experimental investigations often demonstrate that this formulation provides superior tumor suppression compared with free paclitaxel due to sustained drug exposure, improved tumor tissue penetration, and enhanced cellular retention. The nanoformulation also reduces the need for toxic solubilizers like Cremophor EL, enabling researchers to examine drug delivery efficacy without confounding solvent effects.
Paclitaxel Polymeric Micelle’s well-defined particle size distribution (typically 20–100 nm) ensures consistent pharmacological behavior in experimental models. Its high purity (≥99%) guarantees reproducibility across research applications, from mechanistic cancer biology to formulation optimization and nanomedicine development.
Product Specifications
| Item | Details |
|---|---|
| Product Name | Paclitaxel Polymeric Micelle |
| CAS Number | N/A |
| Synonyms | Polymeric Paclitaxel Micelle; PTX Micelle; Nano Paclitaxel |
| Molecular Formula | C47H51NO14 (Paclitaxel core) |
| Molecular Weight | 853.91 g/mol |
| Purity | ≥99% |
| Appearance | White to off-white lyophilized powder |
| Solubility | Soluble in water and ethanol; forms stable micellar solution |
| Storage Temperature | 2–8 °C, protected from light |
| Category | Polymeric nanoparticle formulation |
| Applications | Oncology research, targeted drug delivery, pharmacokinetic and biodistribution studies |
| Formulation | PEG-based micelle incorporating paclitaxel |
| Stability | Stable under recommended laboratory storage conditions |
| Shelf Life | 24 months |
| Supplier Type | Research chemical supplier |
| Intended Use | For laboratory research use only |
| Packaging Options | 10 mg – 1 kg sealed powder in moisture-proof containers |
| Delivery Mode | Cold-chain logistics with tracking and insurance |
Mechanism of Action
Paclitaxel Polymeric Micelle works through two complementary mechanisms:
Microtubule Stabilization (Pharmacodynamic Mechanism)
Nanocarrier-Mediated Drug Delivery (Pharmacokinetic Mechanism)
1. Microtubule Stabilization:
Paclitaxel stabilizes microtubules by binding to β-tubulin subunits, preventing depolymerization and disrupting normal mitotic spindle formation. This leads to mitotic arrest at the G2/M phase and programmed cell death (apoptosis). The polymeric micelle serves as a carrier that ensures controlled release of the active molecule at tumor sites, enabling prolonged cytotoxic exposure.
2. Nanocarrier Drug Delivery:
The polymeric micelle encapsulates paclitaxel in its hydrophobic core, shielding the compound from premature degradation and improving systemic circulation. The hydrophilic corona provides stealth properties, minimizing opsonization and reticuloendothelial clearance. Through passive targeting mechanisms, the nanoparticles accumulate preferentially in tumor tissues exhibiting the EPR effect.
Research Applications:
Tumor-targeted delivery: studying enhanced tumor accumulation and controlled release kinetics.
Pharmacokinetic studies: evaluating biodistribution, circulation half-life, and metabolic fate.
Combination therapy models: investigating co-delivery with other anticancer agents or siRNA molecules.
Cellular uptake analysis: using fluorescence or confocal microscopy to visualize endocytosis and cytoplasmic release.
Paclitaxel Polymeric Micelle provides a reproducible nanomedicine research platform for studying targeted delivery, drug release dynamics, and pharmacological modulation in cancer biology.

Side Effects
While Paclitaxel Polymeric Micelle reduces systemic toxicity compared to conventional formulations, it still exhibits paclitaxel-related cytotoxic effects in preclinical assays:
Mitotic arrest and apoptosis: microtubule stabilization leads to cell cycle arrest and activation of caspase cascades.
Cytoskeletal disruption: inhibition of cell division and motility in rapidly proliferating cells.
Inflammatory responses: mild cytokine induction during nanoparticle uptake.
Oxidative stress modulation: mitochondrial activity alteration during prolonged exposure.
Endothelial barrier effects: temporary changes in cell permeability under high concentrations.
Laboratory Safety Guidelines:
Handle under sterile, ventilated conditions.
Use gloves, mask, and protective clothing.
Avoid inhalation and direct skin contact.
Dispose of waste following institutional nanomaterial safety protocols.
Paclitaxel Polymeric Micelle is for research use only and not for human or veterinary application.
Keywords
Paclitaxel Polymeric Micelle, paclitaxel nanocarrier, polymeric micelle drug delivery, nano paclitaxel formulation, nanoparticle oncology research, controlled release, PEG-PLA micelle, tumor-targeted nanomedicine, anticancer nanoformulation, research chemical supplier.
Shipping Guarantee
All shipments are handled using validated cold-chain logistics systems to maintain micelle stability and prevent degradation. Every order is sealed in moisture-proof packaging with dual-layer insulation and temperature control. Global express couriers with tracking and insurance are employed to ensure timely and secure delivery. Each package includes batch information and Certificate of Analysis (CoA) for verification.
Trade Assurance
We guarantee product authenticity and purity ≥99%, verified through HPLC, DLS, and TEM analysis. Each batch undergoes sterility and particle size validation to ensure reproducibility. Any deviations from specifications are covered by full refund or replacement. Long-term collaboration contracts and bulk-supply traceability are available for research institutes and OEM laboratories.
Payment Support
We provide global, flexible, and secure payment options for international research partners. Accepted methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and digital assets (USDT, Bitcoin, Ethereum). All transactions are protected through SSL encryption and verified gateways. Institutional purchase orders and invoicing are supported for large-scale projects.
Disclaimer
All products are strictly intended for laboratory research use only and not for human or veterinary applications. They are not drugs, medical devices, or diagnostics. Researchers must comply with institutional biosafety and nanomaterial handling protocols. Information is provided solely for scientific and educational reference purposes.



Reviews
There are no reviews yet.